Peptides
Eps8-derived peptide 327 - 1mg
€135.00
Check your price
- Cat.Number : AS-65675
- Manufacturer Ref. :
-
Availability :
In production
Eps8-derived peptide 327 is a human leukocyte antigen (HLA)-A*2402-restricted epitope derived from the Eps8 protein. This peptide may interfere with epidermal growth factor receptor (EGFR) signaling by disrupting Eps8/EGFR complex formation. It has been shown that peptide 327 suppressed cancer cell viability, blocked EGFR signaling and hence changed the regulation of downstream gene expression.
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| Molecular Formula |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Source | |
| Source / Species |
|
Downloads
You may also be interested in the following product(s)
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], 5-FAM labeled - 5 mg
Cat.Number :
AS-29971-5
€1,533.00
Excl. Tax
EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated - 1 mg
Cat.Number :
AS-29972-1
€260.00
Excl. Tax
